STOK - Stoke Qarzning balans kapitallashuviga nisbati

Stoke Therapeutics, Inc. (STOK) tovar belgisi

Stoke Therapeutics (STOK) barqaror daromad oqimlariga ega emas, chunki uning 0.01 darajasidagi moliyaviy holati tashqi moliyalashtirishga bog'liq. Kompaniya ko'rish patologiyalari va epilepsiyaga qarshi dori vositalarini ishlab chiqish orqali risklarni kamaytirmoqda. Ushbu kunlik narxlar grafigi narxlar dinamikasini aks ettirib, RNA terapiyasining kengayish salohiyatini ta'kidlaydi, bu esa tartibga soluvchi organlar tomonidan tasdiqlangach, firma uchun global yetakchilik va yuqori marjalarni ta'minlashi mumkin.

Qarzning balans kapitaliga nisbati: Stoke Therapeutics (STOK) 04.07.2022 - 28.10.2026 uchun

Stoke Therapeutics Inc (STOK) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Stoke Therapeutics|STOK - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Stoke Corp|STOK - Kompaniyani sotib olish narxi
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun buxgalteriya qiymati Stoke Therapeutics|STOK - Jami sof aktivlar|Bozor qiymatining balans qiymatiga nisbati stoketherapeutics.com|STOK - Kompaniya aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Stoke Therapeutics|STOK - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Stoke|STOK - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Stoke Corp
Kompaniyaning barcha koʻrsatkichlari tahlili:STOK, Stoke Therapeutics
Stoke Therapeutics Inc tovar namunasi

Ushbu ko'rsatkich balansdagi kapital tuzilmasi ichida umumiy majburiyatlarning ulushini o'lchaydi, bu esa moliyaviy leverajni va haddan tashqari qarzdorlik xavfini baholash imkonini beradi. Umumiy qarzning kitob kapitalizatsiyasiga nisbatini tahlil qilish orqali investor Stoke Therapeutics (STOK) kompaniyasining barqarorligini tasdiqlashi mumkin, uning rahbariyati qarz mablag'lariga bog'liqlikni minimallashtirgan holda, investitsiya kapitalini jalb qilish orqali gen terapiyasi ishlanmalarini samarali moliyalashtirmoqda.

Stoke Therapeutics (STOK) raqobatchilari

Balans kapitallashuviga qarzlar TEM (Tempus AI Inc)|qiagen.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati IONS (Ionis)|Repligen Corp (RGEN) - Sof aktivlarga qarzlar|RNA - Qarzning balans qiymatiga nisbati|CRSP (CRISPR) - Qarzning balans kapitaliga nisbati|Qarzning balans kapitallashuviga nisbati WGS (GeneDx Holdings Corp.)|Balans qiymatiga qarzlar RARE|Qarzning balans kapitallashuviga nisbati BEAM|Balans kapitallashuviga qarzlar Sarepta Therapeutics (SRPT)|TWST: Balans kapitallashuviga qarzlar|TXG - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Intellia Therapeutics (NTLA)|biolifesolutions.com (BLFS) - Qarzning sof aktivlarga nisbati|WVE - Qarzning balans qiymatiga nisbati|Maze Therapeutics, Inc. (MAZE) - Qarzning balans kapitaliga nisbati|SION - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Prime Medicine Bio|Taysha Gene Therapies - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar QURE (uniqure.com)|Qarzning balans kapitallashuviga nisbati MeiraGTx|Qarzning sof aktivlarga nisbati REGENXBIO Inc RGNX|Solid Bio - Balans kapitallashuviga qarzlar|OCGN: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Pacific Biosciences (PACB)|benitec.com (BNTC) - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar DSGN (Design Therapeutics, Inc.)|Balans qiymatiga qarzlar Rocket Pharma (RCKT)|Qarzning balans qiymatiga nisbati FDMT|Balans kapitallashuviga qarzlar lexeotx.com LXEO|Qarzning balans qiymatiga nisbati Korro Bio (KRRO)|Qarzning balans kapitaliga nisbati editasmedicine.com EDIT|Balans kapitallashuviga qarzlar SLN (Silence Therapeutics plc)|PRQR - Sof aktivlarga qarzlar|CDXS (codexis.com) - Balans kapitallashuviga qarzlar|SGMO (Sangamo BioSciences) - Qarzning balans qiymatiga nisbati|NAUT: Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar MGX|DTIL (Precision BioSciences, Inc.) - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar generationbio.com GBIO|Qarzning balans qiymatiga nisbati Boundless Bio, Inc (BOLD)|Exicure Inc. - Qarzning balans kapitaliga nisbati|IMNN (Celsion Corporation) - Qarzning balans kapitallashuviga nisbati|PHIO: Balans qiymatiga qarzlar|MBIO: Qarzning balans kapitallashuviga nisbati|TransCode Therapeutics, Inc. (RNAZ) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Bionano Genomics Inc. (BNGO)|Qarzning balans qiymatiga nisbati APDN|Qarzning balans kapitallashuviga nisbati bluebird bio, Inc. BLUE|Qarzning balans qiymatiga nisbati immunoprecise.com (IPA)|Balans kapitallashuviga qarzlar OMGA (Omega Therapeutics, Inc.)|Singular Genomics Systems, Inc. - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati RGLS (Regulus Therapeutics Inc)|Syros Pharmaceuticals, Inc (SYRS) - Sof aktivlarga qarzlar|TBIO - Qarzning balans qiymatiga nisbati|TCON (traconpharma.com) - Qarzning balans kapitaliga nisbati|Qarzning balans kapitallashuviga nisbati UBX (Unity Biotechnology, Inc.)